Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018)
Abeona Therapeutics (ABEO) recorded quarterly Construction in Progress of $409000.0 in Q4 2018, down 10.11% quarter-over-quarter from $455000.0 in Q4 2017, and down 10.11% on a YoY basis from $455000.0 in Q4 2017.
Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018) Analysis & Trends
Abeona Therapeutics' Construction in Progress history runs 2 years deep, the most recent figure standing at $409000.0 for Q4 2018.
- In Q4 2018, Construction in Progress fell 10.11% year-over-year to $409000.0; the TTM figure through Dec 2018 stood at $409000.0 (down 10.11% YoY), while the FY2018 annual figure was $409000.0, down 10.11% from the prior year.
- Construction in Progress was $409000.0 for Q4 2018 at Abeona Therapeutics, down from $455000.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $455000.0 in Q4 2017 to a low of $409000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Abeona Therapeutics | 325.29 Mn | 157.02 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 409,000.00 |
| Dec 31, 2017 | 455,000.00 |